344
Views
10
CrossRef citations to date
0
Altmetric
PREGNANCY

Risk factors of gestational diabetes mellitus during assisted reproductive technology procedures

, , &
Pages 318-321 | Received 03 Apr 2019, Accepted 23 Jul 2019, Published online: 21 Aug 2019

References

  • Carracher AM, Marathe PH, Close KL. International diabetes federation 2017. J Diabetes. 2018;10:353–356.
  • Lavery JA, Friedman AM, Keyes KM, et al. Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010. BJOG. 2017;124:804–813.
  • Filardi T, Tavaglione F, Di Stasio M, et al. Impact of risk factors for gestational diabetes (GDM) on pregnancy outcomes in women with GDM. J Endocrinol Invest. 2018;41:671–676.
  • Wang C, Wei Y, Zhang X, et al. A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women. Am J Obstet Gynecol. 2017;216:340–351.
  • Ashrafi M, Gosili R, Hosseini R, et al. Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques. Eur J Obstet Gyn RB. 2014;176:149–152.
  • Healy DL, Breheny S, Halliday J, et al. Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia. Hum Reprod. 2010;25:265–274.
  • Opdahl S, Henningsen AA, Tiitinen A, et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. 2015;30:1724–1731.
  • Pandey S, Shetty A, Hamilton M, et al. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update. 2012;18:485–503.
  • Rosenberg T, Pariente G, Sergienko R, et al. Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet. 2011;284:47–51.
  • Zhang J, Ding Y, Yu L. Association of assisted reproductive technology with adverse pregnancy outcomes. Int J Reprod Biomed. 2015;13:169–180.
  • Huang L, Yen C, Lee S, et al. The pregnancy health and birth outcomes of women who underwent assisted reproductive technology: results of a national survey. Iran Reprod Med. 2011;9:269–276.
  • Bals-Pratsch M, Malfertheiner SF. Glucose metabolism and assisted reproduction. Gynakol Endokrinol. 2017;15:108–115.
  • Ashrafi M, Sheikhan F, Arabipoor A, et al. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS). Eur J Obstet Gynecol Reprod Biol. 2014;181:195–199.
  • Jie Z, Yiling D, Ling Y. Association of assisted reproductive technology with adverse pregnancy outcomes. Iran J Reprod Med. 2015;13:169–180.
  • Hayashi M, Nakai A, Satoh S, et al. Adverse obstetric and perinatal outcomes of singleton pregnancies may be related to maternal factors associated with infertility rather than the type of assisted reproductive technology procedure used. Fertil Steril. 2012;98:922–928.
  • Basevi V, Di Mario S, Morciano C, et al. Comment on: American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care. 2011;34:S11–S61.
  • Balasch J, Gratacos E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol. 2012;24:187–193.
  • Carolan M, Frankowska D. Advanced maternal age and adverse perinatal outcome: a review of the evidence. Midwifery. 2011;27:793–801.
  • Mission JF, Marshall NE, Caughey AB. Pregnancy risks associated with obesity. Obstet Gynecol Clin North Am. 2015;42:335–353.
  • Shen J, Zhang Z, Chen K, et al. Prepregnancy obesity status and risks on pregnancy outcomes in Shanghai: a prospective cohort study. Medicine (Baltimore). 2018;97:e12670.
  • Chu SY, Callaghan WM, Kim SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30:2070–2076.
  • Kim SY, England L, Wilson HG, et al. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health. 2010;100:1047–1052.
  • Frankenthal D, Hirsh-Yechezkel G, Boyko V, et al. The effect of body mass index (BMI) and gestational weight gain on adverse obstetrical outcomes in pregnancies following assisted reproductive technology as compared to spontaneously conceived pregnancies. Obes Res Clin Pract. 2018;13:150–155.
  • Feng Y, Jiang CD, Chang AM, et al. Interactions among insulin resistance, inflammation factors, obesity-related gene polymorphisms, environmental risk factors, and diet in the development of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2019;32:339–347.
  • Gandhi P, Farrell T. Gestational diabetes mellitus (GDM) screening in morbidly obese pregnant women. Eur J Obstet Gynecol Reprod Biol. 2011;159:329–332.
  • Royster GD, Krishnamoorthy K, Csokmay JM, et al. Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology? Fertil Steril. 2016;106:363–370.e3.
  • Berntsen S, Pinborg A. Large for gestational age and macrosomia in singletons born after frozen/thawed embryo transfer (FET) in assisted reproductive technology (ART). Birth Defects Res. 2018;110:630–643.
  • Wei D, Liu JY, Sun Y, et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. Lancet. 2019;393:1310–1318.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.